Skip to main content
. 2022 Jan 24;19:9. doi: 10.1186/s12989-021-00446-7

Table 3.

Descriptive table of the reported symptoms during each exposure scenario

Any reported symptom Eyea Throatb Nosec Chestd
Yes/total % P (χ2- test) Yes/total % P (χ2- test) Yes/total % P (χ2- test) Yes/total % Yes/total %
FA 5/18 28 3/18 17 ref 2/18 11 ref 1/18 6 0/18 0
HVONOx 12/19 63 0.031 7/19 37 0.27 e 8/19 42 0.062e 2/19 11 1/19 5
HVOPM+NOx 14/18 78 0.003 8/18 44 0.07 9/18 50 0.011 5/18 28 3/18 17

Descriptive table of the number of volunteers reporting any type of symptoms, symptoms categorized by type, and χ2-tests for any reported symptoms, eye and throat symptoms. The χ2-tests are compared to the FA exposure. χ2-tests were not performed for nose and chest symptoms due to the low number of reported symptoms. The number of subjects was 19 for HVONOx and 18 for FA and HVOPM+NOx

aItching, running and/or sore eyes. bSore/dry/irritated throat. cRunning nose and/or nose congestion. dChest tightness/breathlessness. ep values obtained from Fisher exact test